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Transfusion-associated hyperkalemic cardiac arrest
(TAHCA) is an adverse event that can occur after the
transfusion of red blood cells (RBCs). During refrigerated
storage, RBCs undergo a series of morphological, functional,
and metabolic changes that are collectively termed ‘the red
blood cell storage lesion’. Specifically, refrigeration impairs
cation transporters, including Na+/K+ ATPase, which leads to a
progressive increase in extracellular potassium within the RBC
unit. Rapid or large volume transfusions of RBC units with
elevated potassium can predispose patients to hyperkalemia,
electrical instabilities, and cardiac arrest.
Expert panels recognize that pediatric patients are
a sensitive population that are at an increased risk of
developing a transfusion reaction compared to their adult
counterparts. Despite this, many studies have focused on the
adult population. Human-induced pluripotent stem cell derived
cardiomyocytes (hiPSC-CM), mimic immature heart tissue and
allows for the characterization of cardiac responses to a variety
of treatments and exposures.
Studying the electrophysiological differences that
are provoked by aged RBCs as well as the irradiation status of
the blood unit has typically been done on animal models; but
in-vitro examination of human stem cell derived
cardiomyocytes, on a microelectrode array allows for high
throughput, rapid analysis of many clinically relevant cardiac
endpoints.

Objective
We aimed to review the literature on the
incidence of transfusion-associated hyperkalemia, highlight
the association with cardiac electrical instabilities, and identify
potential mitigation strategies to reduce the risk of
hyperkalemia in pediatric patient populations.
Experimentally,
we
examined
the
direct
electrophysiological effects of RBC storage age on hiPSC-CM,
using a microelectrode array system.

RESULTS

RESULTS

INTRODUCTION

We identified 21 case reports and case series documenting TAHCA in
pediatric patients. Hyperkalemia and cardiac arrhythmias were
reported in pediatric patients when blood products were transfused
quickly, were delivered directly to the heart without time for
electrolyte equilibration, or when blood products accumulated
extracellular K+ due to storage time or irradiation. We note that
hyperkalemia and/or TACHCA may be underreported due to
incomplete hemovigilance reporting. Collectively, these reports
suggest that the risk of hyperkalemia may be mitigated by using fresh
blood products, reducing storage time after blood product irradiation,
and implementing manipulations that wash or remove excess
extracellular K+.
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Fig a. Beats per minute, paced
at 1.5 Hz. Fig b. Field potential
duration traces. Fig c. Plot of
hiPSC-CM
spontaneous
beating.
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Table 1. Biochemical analyses of sRBC diluted to 10% volume in KH-buffered media.
Storage age was associated with deviations in the electrolyte composition of sRBC
samples. Mean + SEM,
*value differs significantly from control KH buffer, or **value differs from day 7 sample
(p<0.05). n=3-10 per group

# of
cases

Central
line

Peripheral
line

Age range

Surgical

Medical

Small
volume

Large volume

13

13

1 hour – 17
years

63%

36%

15

15

Table 2. Review article stats.
Total of 36 cases reported in 21 publications.
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Fresh (< 7 days) and standard issue (1-2 week old)
blood products increased the field potential duration time, a
psuedo-QT interval, in hiPSC-CM MEA experiments. Older blood
products nearing expiration arrested the cells and a FPD
measurement could not be measured. Immediately post removal
of the blood product, all hiPSC-CM field potential duration
measurements returned to baseline levels. Cardiac electrical
disturbances were worse with chronological aging leading to
increasing numbers of hiPSC-CM wells capturing at half the pacing
frequency or having a complete loss of capture, suggesting
increased refractoriness.

CONCLUSION
Advances in transfusion medicine have improved the
health of RBCs during storage, yet vulnerable patient populations
experience transfusion-associated hyperkalemia. Additional mitigation
strategies are warranted to reduce the risk of TAHCA, which has a low
rate of survival in pediatric patients.
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